On May 4, 2023 HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, reported that HOOKIPA’s management team will participate in and present at the following upcoming investor conferences (Press release, Hookipa Biotech, MAY 4, 2023, View Source [SID1234631028]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

BofA Securities 2023 Healthcare Conference, May 9-11, Las Vegas

The JMP Securities Life Sciences Conference – May 15-16, New York
Corporate Presentation: May 15, 3:00pm ET

2023 RBC Capital Markets Global Healthcare Conference, May 16-17, New York
Fireside Chat: May 16, 1:35pm ET

For conference presentations that are webcast, links will be available within the Investors & Media section of HOOKIPA’s website at View Source Archived replays will be accessible for 30 days following each event.